Credit Suisse Assumes, Downgrades Medivation (MDVN) to Neutral; Upside Driven By M&A Spec Likely to Fade
Tweet Send to a Friend
Credit Suisse downgraded Medivation (NASDAQ: MDVN) from Outperform to Neutral with a price target of $115.00 (from $98.00) in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
